Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · Real-Time Price · USD
2.985
-0.075 (-2.45%)
At close: May 12, 2025, 4:00 PM
3.020
+0.035 (1.17%)
After-hours: May 12, 2025, 4:49 PM EDT
Organogenesis Holdings Market Cap
Organogenesis Holdings has a market cap or net worth of $378.66 million as of May 12, 2025. Its market cap has decreased by -3.72% in one year.
Market Cap
378.66M
Enterprise Value
319.57M
1-Year Change
-3.72%
Ranking
Category
Stock Price
$2.99
Market Cap Chart
Since January 5, 2017, Organogenesis Holdings's market cap has increased from $376.60M to $378.66M, an increase of 0.55%. That is a compound annual growth rate of 0.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 388.20M | -8.49% |
| Dec 31, 2024 | 424.20M | -21.44% |
| Dec 29, 2023 | 540.00M | 53.32% |
| Dec 30, 2022 | 352.20M | -70.37% |
| Dec 31, 2021 | 1.19B | 46.45% |
| Dec 31, 2020 | 811.60M | 78.10% |
| Dec 31, 2019 | 455.70M | 30.13% |
| Dec 31, 2018 | 350.20M | -8.90% |
| Dec 29, 2017 | 384.40M | 2.07% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |